These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9877115)

  • 1. Slowing down chronic renal failure progression with various antihypertensive agents.
    Jovanović DB; Djukanović L; Naumović R
    Clin Nephrol; 1998 Dec; 50(6):390-2. PubMed ID: 9877115
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of blood pressure control on the progression of renal insufficiency in chronic renal failure.
    Branca GF; Satta A; Faedda R; Soggia G; Olmeo NA; Vacca R; Bartoli E
    Panminerva Med; 1983; 25(4):215-8. PubMed ID: 6672713
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
    Grünfeld JP
    Am J Kidney Dis; 1998 Nov; 32(5):xlvi-xlviii. PubMed ID: 9820437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Features of hypotensive therapy in patients with chronic renal insufficiency].
    Glezer GA; Ratner NA; Charyev M
    Klin Med (Mosk); 1971 Oct; 49(10):110-6. PubMed ID: 5133132
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment and prognosis of renal hypertension].
    Oshima K; Takeda T; Fukuchi S; Abe K; Kajiwara N
    Jpn Circ J; 1974 Apr; 38():Suppl:93-7. PubMed ID: 4406378
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progression of chronic renal insufficiency].
    Rossert J; Fischer E; Venetz JP
    Nephrologie; 1999; 20(1):3-7. PubMed ID: 10081030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled blood pressure reduction in chronic renal insufficiency].
    Buder HW; Precht K
    Dtsch Gesundheitsw; 1968 May; 23(19):879-81. PubMed ID: 5678843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic modalities of hypertension in patients in a state of chronic kidney insufficiency].
    Fillastre JP; Leroy J; Dubois D
    Coeur Med Interne; 1971; 10(2):247-51. PubMed ID: 5568267
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
    Kotzaurek R; Schmidt P; Widhalm F
    Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Causes of arterial hypertension and tactics of its treatment in chronic renal insufficiency at the terminal stage].
    Mazo EB; Maĭdanov ET
    Sov Med; 1975 Jul; (7):22-6. PubMed ID: 1216044
    [No Abstract]   [Full Text] [Related]  

  • 12. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hypotensive and pathogenetic therapy on the propulsive function of the heart in patients with glomerulonephritis].
    Zharko KP; Tarnakina TP; Akhmed DI
    Vrach Delo; 1989 Sep; (9):71-3. PubMed ID: 2609629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and slowing progressive chronic renal failure.
    Curtis B; Barrett BJ; Levin A
    Can Fam Physician; 2001 Dec; 47():2512-8. PubMed ID: 11785282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive therapy in limited renal function].
    Lübbecke F
    Fortschr Med; 1986 Nov; 104(42):793-6. PubMed ID: 3804151
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of hypertension in chronic kidney insufficiency].
    Vorburger C
    Schweiz Med Wochenschr; 1974 Jul; 104(27):946-50. PubMed ID: 4460232
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
    Nestor G; Beroniade V; Tutunaru M
    Med Interna (Bucur); 1970 Jul; 22(7):863-8. PubMed ID: 5479504
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of antihypertensives in advanced renal insufficiency].
    Gasparović V
    Lijec Vjesn; 1985 May; 107(5):217-8. PubMed ID: 4010455
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
    Giverhaug T; Falck A; Eriksen BO
    J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.